We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
+11.55%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$5.44B
AUM Growth
+$597M
Cap. Flow
+$85.3M
Cap. Flow %
1.57%
Top 10 Hldgs %
18.87%
Holding
1,482
New
107
Increased
610
Reduced
590
Closed
99

Sector Composition

Rank Sector Weight
1 Technology 19.2%
2 Financials 10.64%
3 Industrials 8.88%
4 Healthcare 8.57%
5 Consumer Discretionary 7.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABT icon
101
Abbott
ABT
$187B
$11.4M 0.21%
103,199
-3,442
-3% -$344K
SCHW
102
Charles Schwab
SCHW
$184B
$11.3M 0.21%
164,081
+2,905
+2% +$168K
BA icon
103
Boeing
BA
$175B
$11.2M 0.21%
42,999
-10,776
-20% -$2.3M
FBND icon
104
Fidelity Total Bond ETF
FBND
$27.2B
$11.2M 0.21%
+242,755
New +$10.7M
UBER icon
105
Uber
UBER
$144B
$11.1M 0.2%
179,628
-32,066
-15% -$1.68M
VB icon
106
Vanguard Small-Cap ETF
VB
$80.2B
$10.9M 0.2%
51,139
+11,015
+27% +$2.12M
CP icon
107
Canadian Pacific Kansas City
CP
$81.4B
$10.8M 0.2%
136,736
+20,846
+18% +$1.53M
DOW icon
108
Dow Inc
DOW
$20.8B
$10.8M 0.2%
197,054
-13,754
-7% -$703K
ZTS icon
109
Zoetis
ZTS
$32.5B
$10.8M 0.2%
54,681
-1,060
-2% -$188K
CARR icon
110
Carrier Global
CARR
$52.5B
$10.8M 0.2%
187,559
-4,785
-2% -$253K
TXN icon
111
Texas Instruments
TXN
$253B
$10.8M 0.2%
63,075
+974
+2% +$151K
REGN icon
112
Regeneron Pharmaceuticals
REGN
$72.9B
$10.7M 0.2%
12,128
+1,139
+10% +$938K
CRM icon
113
Salesforce
CRM
$149B
$10.6M 0.19%
40,196
+3,194
+9% +$723K
FTCS icon
114
First Trust Capital Strength ETF
FTCS
$8.03B
$10.5M 0.19%
131,065
+5,741
+5% +$437K
ROK icon
115
Rockwell Automation
ROK
$52.4B
$10.3M 0.19%
33,156
+123
+0.4% +$34.5K
NOBL icon
116
ProShares S&P 500 Dividend Aristocrats ETF
NOBL
$11.9B
$10.2M 0.19%
215,114
-4,702
-2% -$211K
KO icon
117
Coca-Cola
KO
$380B
$10.2M 0.19%
173,553
+7,879
+5% +$448K
AMT icon
118
American Tower
AMT
$79.9B
$10.2M 0.19%
47,222
-538
-1% -$102K
CVS icon
119
CVS Health
CVS
$140B
$10.2M 0.19%
128,888
-12,324
-9% -$877K
NOC icon
120
Northrop Grumman
NOC
$78B
$10.2M 0.19%
21,731
-2,223
-9% -$1.04M
BIL icon
121
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$47.1B
$9.94M 0.18%
108,721
+50,709
+87% +$4.64M
BMY icon
122
Bristol-Myers Squibb
BMY
$130B
$9.87M 0.18%
192,330
-15,254
-7% -$801K
PSX icon
123
Phillips 66
PSX
$82.5B
$9.83M 0.18%
73,831
+16,846
+30% +$2.01M
VMI icon
124
Valmont Industries
VMI
$9.33B
$9.83M 0.18%
42,086
-2,967
-7% -$652K
UNP icon
125
Union Pacific
UNP
$175B
$9.73M 0.18%
39,607
-2,930
-7% -$644K

Similar funds

Oppenheimer & Co's Q4 2023 Portfolio in Review

As of Q4 2023, Oppenheimer & Co held 1,482 positions worth $5.44B, up 12% from $4.84B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Oppenheimer & Co's Q4 2023 filing shows 107 new, 610 increased, 590 reduced and 99 closed positions. Its largest new stake was Fidelity Total Bond ETF: 242,755 shares worth $11.2M. The largest sale was Activision Blizzard, an estimated $8.82M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Financials and Industrials.

  • Oppenheimer & Co's largest Q4 2023 buy was Fidelity Total Bond ETF: 242,755 shares worth $11.2M.
  • Oppenheimer & Co added most to Pacer US Cash Cows 100 ETF in Q4 2023, an estimated $19.8M increase.
  • Oppenheimer & Co's biggest Q4 2023 reduction was Chevron, cutting an estimated $6.16M.
  • Oppenheimer & Co fully exited Activision Blizzard in Q4 2023, selling an estimated $8.82M.
  • Oppenheimer & Co's ten largest holdings make up 19% of its $5.44B portfolio in Q4 2023.
  • Oppenheimer & Co opened 107 new positions and closed 99 in Q4 2023.
  • Oppenheimer & Co's portfolio value rose 12% quarter-over-quarter to $5.44B.

Based on Oppenheimer & Co's 13F filing for Q4 2023, filed 13 Feb 2024.